Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome

References

• Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004;27:2819–2823.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Vaz JA. Insulin treatment in diabetic pregnancy. Diabetes Metab Res Rev 2008;24 Suppl 2:S3–20.
   Google Scholar
• Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008;31:9–14.
   PubMed Web of Science ®Google Scholar
• Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, Hansen AS, Mersebach H; Insulin Aspart Pregnancy Study Group. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186.e1–186.e7.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A; Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771–776.
   PubMed Web of Science ®Google Scholar
• Gough SC. A review of human and analogue insulin trials. Diabetes Res Clin Pract 2007;77:1–15.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Damm P, Jovanovic L, McCance DR, Thyregod C, Jensen AB, Hod M. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev 2011;27:543–551.
   PubMed Web of Science ®Google Scholar
• Bruttomesso D, Bonomo M, Costa S, Dal Pos M, Di Cianni G, Pellicano F, Vitacolonna E, et al.; Italian Group for Continuous Subcutaneous Insulin Infusion in Pregnancy. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metab 2011;37:426–431.
   PubMed Web of Science ®Google Scholar
• Di Cianni G, Torlone E, Lencioni C, Bonomo M, Di Benedetto A, Napoli A, Vitacolonna E, et al.; Italian Diabetes and Pregnancy Study Group; Italian Society of Diabetology. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med 2008;25:993–996.
   PubMed Web of Science ®Google Scholar
• Fang YM, MacKeen D, Egan JF, Zelop CM. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics. J Matern Fetal Neonatal Med 2009;22:249–253.
   PubMed Web of Science ®Google Scholar
• Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabet Med 2008;25:165–169.
   PubMed Web of Science ®Google Scholar
• Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther 2008;30:1476–1484.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Di Cianni G, Bruttomesso D, Dalfrà MG, Fresa R, Mello G, Napoli A, et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women. Diabet Med 2009;26:1181–1182.
   PubMed Web of Science ®Google Scholar
• Lepercq J, Jacqueminet S, Hieronimus S, Timsit J, Grimaldi A. Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes. Diabetes Metab 2010;36:209–212.
   PubMedGoogle Scholar
• Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a case-control pilot study. BJOG 2007;114:453–457.
   PubMed Web of Science ®Google Scholar
• Pöyhönen-Alho M, Rönnemaa T, Saltevo J, Ekblad U, Kaaja RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007;86:1171–1174.
   PubMed Web of Science ®Google Scholar
• Smith JG, Manuck TA, White J, Merrill DC. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy. Am J Perinatol 2009;26:57–62.
   PubMed Web of Science ®Google Scholar
• Hod M, McCance DR, Ivanisevic M, Garcia S, Jovanovic L, Mathiesen ER, Damm P. Perinatal outcomes in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes. Diabetologia 2011;54 (Suppl 1):S487–S487.
   Google Scholar
• Mathiesen ER, Damm P, Hod M, McCance DR, Ivanisevic M, Garcia S, Jovanovic L. Maternal glycaemic control and hypoglycaemia in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes. Diabetologia 2011;54 (Suppl 1):S486–S487.
   Google Scholar
• Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009;32:38–44.
   PubMed Web of Science ®Google Scholar
• Vestgaard M, Ringholm L, Laugesen CS, Rasmussen KL, Damm P, Mathiesen ER. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes. Diabet Med 2010;27:431–435.
   PubMed Web of Science ®Google Scholar
• Marsál K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843–848.
   PubMed Web of Science ®Google Scholar
• Wyatt JW, Frias JL, Hoyme HE, Jovanovic L, Kaaja R, Brown F, Garg S, et al.; IONS study group. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 2005;22:803–807.
   PubMed Web of Science ®Google Scholar
• Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, Trüb T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999–1005.
   PubMed Web of Science ®Google Scholar
• Confidential Enquiry into Maternal and Child Health. Pregnancy in women with type 1 and type 2 diabetes in 2002-2003. England, Wales and Northern Ireland. London: CEMACH, 2005.
   Google Scholar
• Fakhoury W, Lockhart I, Kotchie RW, Aagren M, LeReun C. Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes. Pharmacology 2008;82:156–163.
   PubMed Web of Science ®Google Scholar
• Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 2004;47:622–629.
   PubMed Web of Science ®Google Scholar
• Dailey G, Admane K, Mercier F, Owens D. Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir. Diabetes Technol Ther 2010;12:1019–1027.
   PubMedGoogle Scholar
• Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, et al. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study. Diabetes Care 2007;30:2447–2452.
   PubMed Web of Science ®Google Scholar
• Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple RC, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia 2012;55:282–293.
   PubMed Web of Science ®Google Scholar